ANI PHARMACEUTICALS INC

CUSIP: 00182CAC7 Class: NOTE 2.250% 9/0

Holders for Q4 2025 Position Changes for Q4 2025

Note: Option positions (PUT/CALL) are excluded.

InstitutionSharesValue ($000)
CAMDEN ASSET MANAGEMENT L P /CA43,017,000$54,072
Alberta Investment Management Corp30,000,000$37,923
MILLENNIUM MANAGEMENT LLC24,000,000$30,285
HBK INVESTMENTS L P22,650,000$28,589
Empyrean Capital Partners, LP21,000,000$26,486
CITADEL ADVISORS LLC15,000,000$18,919
Brevan Howard Capital Management LP15,000,000$19,104
JPMORGAN CHASE & CO13,009,000$16,684
ABSOLUTE INVESTMENT ADVISERS, LLC11,473,000$14,456
BlackRock, Inc.11,060,000$13,902
Context Capital Management, LLC10,000,000$12,620
CITIGROUP INC8,070,000$10,144
Jefferies Financial Group Inc.7,620,000$9,644
Point72 Asset Management, L.P.7,500,000$9,458
Universal- Beteiligungs- und Servicegesellschaft mbH5,310,000$6,767
GABELLI FUNDS LLC5,050,000$6,384
SUSQUEHANNA ADVISORS GROUP, INC.5,000,000$63
PICTON MAHONEY ASSET MANAGEMENT4,000,000$5,048
FMR LLC2,564,000$3,223
BNP PARIBAS ARBITRAGE, SA1,540,000$1,936
GOLDMAN SACHS GROUP INC1,500,000$1,886
LAZARD ASSET MANAGEMENT LLC960,000$12
Bank of New York Mellon Corp850,000$1,090
MORGAN STANLEY837,000$1,052
Calamos Advisors LLC39,000$49
Boussard & Gavaudan Investment Management LLP18,500$23,580
Total (26 institutions)267,067,500$353,376